- Home
- CMPX vs HCAT Comparison
CMPX vs HCAT Comparison
Compare CMPX & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- HCAT
- Stock Information
- Founded
- CMPX 2014
- HCAT 2008
- Country
- CMPX United States
- HCAT United States
- Employees
- CMPX N/A
- HCAT N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- HCAT Computer Software: Programming Data Processing
- Sector
- CMPX Health Care
- HCAT Technology
- Exchange
- CMPX Nasdaq
- HCAT Nasdaq
- Market Cap
- CMPX 291.8M
- HCAT 237.9M
- IPO Year
- CMPX N/A
- HCAT 2019
- Fundamental
- Price
- CMPX $3.51
- HCAT $2.81
- Analyst Decision
- CMPX Strong Buy
- HCAT Hold
- Analyst Count
- CMPX 8
- HCAT 11
- Target Price
- CMPX $13.50
- HCAT $4.70
- AVG Volume (30 Days)
- CMPX 876.2K
- HCAT 849.1K
- Earning Date
- CMPX 11-11-2025
- HCAT 11-05-2025
- Dividend Yield
- CMPX N/A
- HCAT N/A
- EPS Growth
- CMPX N/A
- HCAT N/A
- EPS
- CMPX N/A
- HCAT N/A
- Revenue
- CMPX N/A
- HCAT $316,093,000.00
- Revenue This Year
- CMPX N/A
- HCAT $4.52
- Revenue Next Year
- CMPX N/A
- HCAT $0.57
- P/E Ratio
- CMPX N/A
- HCAT N/A
- Revenue Growth
- CMPX N/A
- HCAT 5.55
- 52 Week Low
- CMPX $1.27
- HCAT $2.52
- 52 Week High
- CMPX $4.08
- HCAT $9.24
- Technical
- Relative Strength Index (RSI)
- CMPX 59.49
- HCAT 34.00
- Support Level
- CMPX $3.37
- HCAT $2.87
- Resistance Level
- CMPX $3.77
- HCAT $3.42
- Average True Range (ATR)
- CMPX 0.19
- HCAT 0.17
- MACD
- CMPX 0.01
- HCAT -0.04
- Stochastic Oscillator
- CMPX 46.87
- HCAT 1.98
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.